Sertraline for treatment of depression.
D015057:1-Naphthylamine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy*; D006801:Humans; D014179:Neurotransmitter Uptake Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D012701:Serotonin / Q000502:physiology*; D020280:Sertraline
D014179:Neurotransmitter Uptake Inhibitors; D012701:Serotonin; D015057:1-Naphthylamine; D020280:Sertraline